The Food and Drug Administration warned on Tuesday that COVID-19 antigen tests may be significantly less able to detect Omicron, the rapidly escalating variant of COVID.
The recent warning is based on early research from the National Institutes of Health’s Rapid Acceleration of Diagnostics initiative using samples from patients with live viruses - survey that “represents the best way to evaluate true test performance in the short-term,” as stated by the FDA.
On Tuesday, the FDA stated...
